Gwen Watanabe

Gwen Watanabe

Gwen Watanabe is a Managing Director at H.I.G. BioHealth Partners and a Board Member (Governance and Compensation Committee Member) at On Target Laboratories.23456

Key facts about Gwen Watanabe:

• She has over 30 years of extensive global experience as a MedDevice and MedTech Executive.2
• Previously, she served as the General Manager and Vice President of US Robotics for Smith and Nephew and as the Corporate Vice President of Global Corporate Development, Strategy and Strategic Relationships at Teleflex.2
• Gwen co-founded several medical device companies including Hotspur Technologies, Nellix Endovascular, Bacchus Vascular and AneuRx, all of which were later acquired by larger strategic players.12
• She currently serves on the board of Compute Health and is an observer on the board of Augmedics.12
• Gwen holds an M.S. in Mechanical Engineering from Stanford University, an MBA from Harvard Business School, and a B.S. in Mechanical Engineering from MIT where she simultaneously completed her pre-med requirements.12

As a Board Member at On Target Laboratories, Gwen provides strategic guidance and oversight to help the company commercialize its novel CYTALUX technology, which illuminates lung and ovarian cancer during surgery.345 Her extensive experience in the medical device industry and track record of building successful companies makes her a valuable asset to On Target Laboratories as it brings this innovative cancer imaging agent to more patients.45